Hoya (OTCMKTS:HOCPY) Raised to "Strong-Buy" at The Goldman Sachs Group

Key Points

• Hoya (OTCMKTS:HOCPY) received an upgrade from The Goldman Sachs Group, moving its rating to strong-buy from a previous rating of 'hold'.
• Erste Group Bank also upgraded Hoya to a strong-buy rating, indicating a positive outlook from multiple analysts.
• Hoya reported earnings per share of $0.98 for the last quarter, slightly missing consensus estimates, but had revenue of $1.52 billion, surpassing expectations.

The Goldman Sachs Group upgraded shares of Hoya (OTCMKTS:HOCPY - Free Report) from a hold rating to a strong-buy rating in a report released on Wednesday, July 23rd,Zacks.com reports.

Separately, Erste Group Bank raised shares of Hoya from a "hold" rating to a "strong-buy" rating in a research note on Friday, May 23rd.

Hoya Price Performance

HOCPY stock traded down $0.66 during midday trading on Wednesday, reaching $127.72. The company had a trading volume of 58,716 shares, compared to its average volume of 35,257. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.90 and a quick ratio of 4.21. Hoya has a 1 year low of $97.49 and a 1 year high of $148.27. The company has a market capitalization of $43.82 billion, a P/E ratio of 33.52, a P/E/G ratio of 2.57 and a beta of 0.90. The firm has a 50-day moving average price of $120.19 and a 200-day moving average price of $120.18.

Hoya (OTCMKTS:HOCPY - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The technology company reported $0.98 EPS for the quarter, missing analysts' consensus estimates of $0.99 by ($0.01). Hoya had a return on equity of 20.43% and a net margin of 23.22%. The company had revenue of $1.52 billion during the quarter, compared to analysts' expectations of $1.50 billion. On average, research analysts anticipate that Hoya will post 3.66 earnings per share for the current fiscal year.

Hoya Company Profile

HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.